Correlation Between Icosavax and Pliant Therapeutics
Can any of the company-specific risk be diversified away by investing in both Icosavax and Pliant Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Icosavax and Pliant Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Icosavax and Pliant Therapeutics, you can compare the effects of market volatilities on Icosavax and Pliant Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Icosavax with a short position of Pliant Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Icosavax and Pliant Therapeutics.
Diversification Opportunities for Icosavax and Pliant Therapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Icosavax and Pliant is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Icosavax and Pliant Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pliant Therapeutics and Icosavax is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Icosavax are associated (or correlated) with Pliant Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pliant Therapeutics has no effect on the direction of Icosavax i.e., Icosavax and Pliant Therapeutics go up and down completely randomly.
Pair Corralation between Icosavax and Pliant Therapeutics
If you would invest 1,278 in Pliant Therapeutics on August 31, 2024 and sell it today you would earn a total of 75.00 from holding Pliant Therapeutics or generate 5.87% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 1.59% |
Values | Daily Returns |
Icosavax vs. Pliant Therapeutics
Performance |
Timeline |
Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pliant Therapeutics |
Icosavax and Pliant Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Icosavax and Pliant Therapeutics
The main advantage of trading using opposite Icosavax and Pliant Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Icosavax position performs unexpectedly, Pliant Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pliant Therapeutics will offset losses from the drop in Pliant Therapeutics' long position.Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Pliant Therapeutics vs. Relay Therapeutics | Pliant Therapeutics vs. Stoke Therapeutics | Pliant Therapeutics vs. Black Diamond Therapeutics | Pliant Therapeutics vs. Arvinas |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |